Governance dispute over the BNC project has intensified once again. According to reports, YZi Labs recently issued a statement on social media expressing doubts about a series of measures taken by CEA Industries (BNC) — particularly the introduction of a poison pill plan and bylaws amendment initiatives. YZi Labs believes these measures essentially restrict shareholders from exercising written consent rights, effectively strengthening the board's power, which contradicts the original intent of protecting shareholder interests.

More notably, YZi Labs refuted BNC's claim that they "never considered alternative token solutions." They pointed out that BNC's CEO David Namdar explicitly stated relevant considerations in January 2025. This discrepancy in messaging and information asymmetry further exacerbates market concerns about the project's transparency.

This governance-level tug-of-war reflects the internal checks and balances issues many Web3 projects face during their rapid expansion phase. The balance between shareholder rights protection and board power division appears to have become a key test of a project's governance level.